Alembic Pharmaceuticals Ltd has received final approval from the US Food and Drug Administration for prazosin hydrochloride capsules USP in 1 mg, 2 mg, and 5 mg strengths, the company said in an exchange filing.
The drug is a generic version of Pfizer Inc's Minipress capsules.
It is indicated for the treatment of hypertension to lower blood pressure.
According to data by IQVIA, the drug had sales of approximately $50 mln for the 12-month period ended December.
Bombay HC Quashes Flag Dishonour Case Against 85-Year-Old Man, Says Mere Presence Not Crime
BMC Initiates E-Auction Of 12 Properties To Recover ₹378.63 Crore In Tax Dues
MNS Workers Thrash Youth In Virar For Offensive Remarks Against Marathi Language
Mumbai News: Colaba Football Ground Astro-Turfing Cancelled After Local Protests; MLA Rahul Narwekar Confirms Mud Pitch Will Be Retained
Shares of the company traded 0.8% lower at ₹521.05 on the NSE, at 09:15 IST.
